TRUECAR INC (TRUE) Fundamental Analysis & Valuation

NASDAQ:TRUE • US89785L1070

Current stock price

2.54 USD
+0.33 (+14.93%)
At close:
2.54 USD
0 (0%)
After Hours:

This TRUE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TRUE Profitability Analysis

1.1 Basic Checks

  • In the past year TRUE has reported negative net income.
  • In the past year TRUE had a positive cash flow from operations.
  • In the past 5 years TRUE reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: TRUE reported negative operating cash flow in multiple years.
TRUE Yearly Net Income VS EBIT VS OCF VS FCFTRUE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • TRUE has a Return On Assets of -12.52%. This is in the lower half of the industry: TRUE underperforms 68.57% of its industry peers.
  • The Return On Equity of TRUE (-16.30%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.52%
ROE -16.3%
ROIC N/A
ROA(3y)-30.33%
ROA(5y)-16.84%
ROE(3y)-39.17%
ROE(5y)-21.83%
ROIC(3y)N/A
ROIC(5y)N/A
TRUE Yearly ROA, ROE, ROICTRUE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • The Gross Margin of TRUE (79.17%) is better than 75.71% of its industry peers.
  • In the last couple of years the Gross Margin of TRUE has declined.
  • TRUE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.04%
GM growth 5Y-1.56%
TRUE Yearly Profit, Operating, Gross MarginsTRUE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. TRUE Health Analysis

2.1 Basic Checks

  • TRUE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TRUE has been reduced compared to 1 year ago.
  • TRUE has less shares outstanding than it did 5 years ago.
  • TRUE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TRUE Yearly Shares OutstandingTRUE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TRUE Yearly Total Debt VS Total AssetsTRUE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -0.53, we must say that TRUE is in the distress zone and has some risk of bankruptcy.
  • TRUE's Altman-Z score of -0.53 is on the low side compared to the rest of the industry. TRUE is outperformed by 68.57% of its industry peers.
  • There is no outstanding debt for TRUE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.53
ROIC/WACCN/A
WACC8.9%
TRUE Yearly LT Debt VS Equity VS FCFTRUE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • TRUE has a Current Ratio of 4.49. This indicates that TRUE is financially healthy and has no problem in meeting its short term obligations.
  • TRUE's Current ratio of 4.49 is amongst the best of the industry. TRUE outperforms 82.86% of its industry peers.
  • TRUE has a Quick Ratio of 4.49. This indicates that TRUE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.49, TRUE belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.49
Quick Ratio 4.49
TRUE Yearly Current Assets VS Current LiabilitesTRUE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TRUE Growth Analysis

3.1 Past

  • The earnings per share for TRUE have decreased strongly by -86.44% in the last year.
  • TRUE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.18%.
  • The Revenue for TRUE have been decreasing by -12.12% on average. This is quite bad
EPS 1Y (TTM)-86.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)6.18%
Revenue growth 3Y-8.83%
Revenue growth 5Y-12.12%
Sales Q2Q%-7.17%

3.2 Future

  • TRUE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.95% yearly.
  • TRUE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.96% yearly.
EPS Next Y-88.42%
EPS Next 2Y-14.66%
EPS Next 3Y-5.97%
EPS Next 5Y17.95%
Revenue Next Year6.64%
Revenue Next 2Y7.33%
Revenue Next 3Y9.96%
Revenue Next 5Y7.96%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TRUE Yearly Revenue VS EstimatesTRUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
TRUE Yearly EPS VS EstimatesTRUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. TRUE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TRUE. In the last year negative earnings were reported.
  • Also next year TRUE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRUE Price Earnings VS Forward Price EarningsTRUE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRUE Per share dataTRUE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • TRUE's earnings are expected to decrease with -5.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.66%
EPS Next 3Y-5.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRUE Dividend Analysis

5.1 Amount

  • TRUE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRUE Fundamentals: All Metrics, Ratios and Statistics

TRUECAR INC

NASDAQ:TRUE (1/21/2026, 8:00:01 PM)

After market: 2.54 0 (0%)

2.54

+0.33 (+14.93%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-06
Earnings (Next)02-16
Inst Owners77.19%
Inst Owner Change-0.19%
Ins Owners2.45%
Ins Owner Change-10.19%
Market Cap225.91M
Revenue(TTM)181.22M
Net Income(TTM)-18.61M
Analysts50
Price Target2.7 (6.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.59%
Min EPS beat(2)11.76%
Max EPS beat(2)201.42%
EPS beat(4)3
Avg EPS beat(4)48.15%
Min EPS beat(4)-22.55%
Max EPS beat(4)201.42%
EPS beat(8)7
Avg EPS beat(8)37.72%
EPS beat(12)10
Avg EPS beat(12)33.51%
EPS beat(16)11
Avg EPS beat(16)11.61%
Revenue beat(2)1
Avg Revenue beat(2)-4.31%
Min Revenue beat(2)-11.93%
Max Revenue beat(2)3.31%
Revenue beat(4)1
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-11.93%
Max Revenue beat(4)3.31%
Revenue beat(8)2
Avg Revenue beat(8)-3.06%
Revenue beat(12)2
Avg Revenue beat(12)-3.71%
Revenue beat(16)2
Avg Revenue beat(16)-5.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-14.95%
EPS NQ rev (3m)-14.95%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.17%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.25
P/FCF N/A
P/OCF 28.76
P/B 1.98
P/tB 1.98
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.09
OCFY3.48%
SpS2.04
BVpS1.28
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.52%
ROE -16.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.17%
FCFM N/A
ROA(3y)-30.33%
ROA(5y)-16.84%
ROE(3y)-39.17%
ROE(5y)-21.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.04%
GM growth 5Y-1.56%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.29%
Cap/Sales 4.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.49
Quick Ratio 4.49
Altman-Z -0.53
F-Score6
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)60.34%
Cap/Depr(5y)59.43%
Cap/Sales(3y)6.38%
Cap/Sales(5y)5.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-88.42%
EPS Next 2Y-14.66%
EPS Next 3Y-5.97%
EPS Next 5Y17.95%
Revenue 1Y (TTM)6.18%
Revenue growth 3Y-8.83%
Revenue growth 5Y-12.12%
Sales Q2Q%-7.17%
Revenue Next Year6.64%
Revenue Next 2Y7.33%
Revenue Next 3Y9.96%
Revenue Next 5Y7.96%
EBIT growth 1Y-1.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.64%
EBIT Next 3Y31.94%
EBIT Next 5Y19.34%
FCF growth 1Y99.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y130.74%
OCF growth 3Y-18.43%
OCF growth 5Y-17.65%

TRUECAR INC / TRUE Fundamental Analysis FAQ

What is the fundamental rating for TRUE stock?

ChartMill assigns a fundamental rating of 3 / 10 to TRUE.


What is the valuation status of TRUECAR INC (TRUE) stock?

ChartMill assigns a valuation rating of 0 / 10 to TRUECAR INC (TRUE). This can be considered as Overvalued.


Can you provide the profitability details for TRUECAR INC?

TRUECAR INC (TRUE) has a profitability rating of 1 / 10.